Immuneering Share Price

Immuneering Share Price

NASDAQ: IMRX | Micro Cap | Healthcare
$3.48
+$0.02 (0.58%) Last updated on 19 Nov, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Immuneering Stock Performance

Open
$3.56
Prev. Close
$3.46
Circuit Range
N/A
Day Range
$3.43 - $3.56
Year Range
$3.31 - $8.47
Volume
19,459
Average Traded
$3.49

Immuneering Share Price Today

As of 19 November 2026, Immuneering Corporation Class A's share price is $3.48. The stock opened at $3.56, compared to its previous close of $3.46. During today's trading session, Immuneering Corporation Class A's share price traded between $3.43 and $3.56, with an average price of $3.50. Over the past 52 weeks, the stock has recorded a high of $8.47 and a low of $3.31. In terms of performance, Immuneering Corporation Class A's share price has declined by 39.79% over the last six months and is down 54.63% on a year-on-year basis.

Immuneering Share Price Chart

Line chart of the Immuneering price trend over the selected period. The price rose overall, ranging from 3.44 to 3.56, ending at 3.48.
$3.43$3.56
L
Show Current Price
H

Immuneering Stock Fundamentals & Key Indicators

Market Cap
$153.16M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.03
Revenue (TTM)
$0.00
Return On Equity (TTM)
-39.43%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-108.89%

Immuneering Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$11.58-$13.46-$17.27-$24.19
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-16.23%-28.31%-40.07%

Immuneering Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.32$0.00$0.00$0.00
Net Profit-$50.51-$53.47-$61.04-$56.02
Net Profit Margin-15784.38%N/AN/AN/A
Income ChangeN/A-5.86%-14.16%8.22%

Immuneering Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets55.7413.1313.513.62
Current Assets176.2539.5989.08108.75
Total Assets231.9952.71102.58122.37
Non Current Liabilities3.433.824.164.46
Current Liabilities10.077.57.858.05
Total Liabilities13.511.3312.0112.52
Shareholders' Equity218.4841.3990.58109.85

Immuneering Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-45.34-55.0-48.97-44.1
Investing-88.7426.437.341.83
Financing226.585.328.440.02

About Immuneering

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Immuneering Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.81
$3.48
-6.70%
Oct 2026
$4.11
$3.73
-9.25%
Sep 2026
$4.92
$4.11
-21.34%
Aug 2026
$4.13
$5.22
+26.51%
Jul 2026
$5.10
$4.13
-17.23%
Jun 2026
$5.65
$4.99
-13.67%
May 2026
$5.21
$5.78
+9.99%
Apr 2026
$5.29
$5.25
-0.10%
Mar 2026
$4.86
$5.26
+4.99%
Feb 2026
$4.62
$5.01
+8.09%
Jan 2026
$6.53
$4.63
-29.45%
Dec 2025
$7.47
$6.57
-14.34%

Immuneering Share Price FAQs